Gene · 3595
Papers1,950
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,950
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Corrigendum to "Integrated bioinformatics and machine learning deciphering IL12RB2 and FYN as key immune biomarkers in brucellosis" [Int. Immunopharmacol. 173 (2026) 116268]. | Int Immunopharmacol | 2026 | 41692670 | PubTator, text mining | PubMed |
| Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2026 | 41683630 | PubTator, text mining | PubMed |
| Complete and partial forms of X-linked MCTS1 deficiency in patients with mycobacterial disease. | J Hum Immun | 2026 | 41623352 | PubTator, text mining | PubMed |
| Integrated bioinformatics and machine learning deciphering IL12RB2 and FYN as key immune biomarkers in brucellosis. | Int Immunopharmacol | 2026 | 41605052 | PubTator, text mining | PubMed |
| Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants. | Sci Adv | 2026 | 41576166 | PubTator, text mining | PubMed |
| Current Therapies and Potential Strategies for Uveal Melanoma. | Drugs Drug Candidates | 2025 | 41737289 | PubTator, text mining | PubMed |
| Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome. | Nat Commun | 2025 | 41419472 | PubTator, text mining | PubMed |
| Revealing Causal Protein Biomarkers and Potential Therapeutic Targets for Histologic-Specific Lung Cancer. | J Cell Mol Med | 2025 | 41340014 | PubTator, text mining | PubMed |
| Association of IL12RB2, RORC, and class II HLA polymorphisms with severe erythema multiforme of regorafenib in Japanese patients with colorectal cancer. | Cancer Chemother Pharmacol | 2025 | 41284062 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Rare Genetic Variants in Saudi COVID-19 Patients with Extreme Phenotypes. | Viruses | 2025 | 41012626 | PubTator, text mining | PubMed |
| Lung NR3C1+ and CXCR6high T cells distinguish immunopathogenesis of human emphysema. | Commun Biol | 2025 | 40993192 | PubTator, text mining | PubMed |
| Genetically proxied glucagon-like peptide-1 receptor agonist is associated with risk of tubulo-interstitial nephritis: A network Mendelian randomization study. | Medicine (Baltimore) | 2025 | 40988251 | PubTator, text mining | PubMed |
| Predisposing Factors, Control Strategies, and Antiviral Therapy of Mpox Virus as a Potential Zoonotic Agent. | Vector Borne Zoonotic Dis | 2025 | 40955742 | PubTator, text mining | PubMed |
| Regulatory mechanisms of Th9 cell differentiation. | Front Immunol | 2025 | 40948790 | PubTator, text mining | PubMed |
| Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles. | Exp Hematol Oncol | 2025 | 40855348 | PubTator, text mining | PubMed |
| PS77: a novel peptide with α-helical structure for targeted anti-inflammatory therapy in biomaterials design. | Immunol Res | 2025 | 40705171 | PubTator, text mining | PubMed |
| Metabolic reprogramming and immune microenvironment characteristics in laryngeal carcinoma: advances in immunotherapy. | Front Immunol | 2025 | 40370437 | PubTator, text mining | PubMed |
| STAT Signature Dish: Serving Immunity with a Side of Dietary Control. | Biomolecules | 2025 | 40305224 | PubTator, text mining | PubMed |
| Epigenetic markers of disease risk and psychotherapy response in anxiety disorders - a longitudinal analysis of the DNA methylome. | Mol Psychiatry | 2025 | 40281224 | PubTator, text mining | PubMed |
| Taming interleukin-12: Engineering of bispecific antibody-based IL-12 mimetics with biased agonism capacities. | Protein Sci | 2025 | 39981925 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3595/papers?page=2